Autolus Therapeutics reported revenue of $45.69M and net income of -$39.11M for the quarter ended Jun 2026, up 408.7% year over year. This income statement covers 34 quarters of results from Sep 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2017 | Dec2017 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||||||||
| Revenue | 1.51M | 0.24M | 0.17M | 2.37M | 3.66M | 1.29M | 0.41M | 10.09M | 0.03M | 8.98M | 20.92M | 21.19M | 24.29M | 45.69M | ||||||||||||||||||||
| Cost of RevenueCost of Rev | 11.39M | 17.95M | 24.45M | 28.64M | 25.33M | 20.47M | ||||||||||||||||||||||||||||
| Gross Profit | 10.09M | -11.36M | -8.97M | -3.52M | -7.45M | -1.04M | 25.22M | |||||||||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 32.13M | 32.29M | 15.69M | 28.36M | 30.79M | 31.48M | 7.55M | 27.39M | 33.23M | 32.32M | 37.54M | 30.67M | 36.61M | 40.32M | 30.83M | 26.73M | 27.43M | 27.89M | 35.63M | 27.90M | ||||||||||||||
| Selling, General & AdministrativeSG&A | 7.24M | 8.30M | 7.59M | 7.99M | 8.27M | 8.23M | 7.41M | 9.28M | 11.12M | 10.61M | 15.73M | 18.18M | 21.90M | 27.33M | 34.31M | 29.53M | 30.27M | 36.28M | 35.80M | 41.16M | ||||||||||||||
| Other Operating ExpensesOther Opex | -0.52M | -3.77M | -0.02M | -0.22M | -0.00M | 25.33M | 20.47M | |||||||||||||||||||||||||||
| Operating ExpensesOpex | 39.37M | 40.59M | 23.28M | 36.35M | 39.06M | 39.72M | 14.96M | 36.67M | 44.35M | 42.93M | 53.27M | 48.85M | 58.93M | 67.88M | 75.89M | 74.22M | 82.14M | 92.81M | 96.75M | 89.53M | ||||||||||||||
| Operating IncomeOp. Inc | -37.72M | -40.35M | -23.10M | -36.19M | -39.06M | -37.35M | -11.65M | -39.15M | -44.38M | -42.91M | -53.27M | -38.76M | -58.93M | -67.88M | -75.86M | -65.24M | -61.22M | -71.62M | -72.47M | -43.84M | ||||||||||||||
| EBIT | -37.72M | -40.35M | -23.10M | -36.19M | -39.06M | -37.35M | -11.65M | -39.15M | -44.38M | -42.91M | -53.27M | -38.76M | -58.93M | -67.88M | -75.86M | -65.24M | -61.22M | -71.62M | -72.47M | -43.84M | ||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 1.10M | 1.79M | 1.81M | 1.85M | 3.46M | 4.91M | 5.02M | 5.01M | 30.13M | 19.27M | 10.17M | 10.69M | -30.84M | 10.14M | -6.83M | 10.52M | 22.84M | -2.67M | ||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.04M | 0.03M | 0.15M | 0.03M | 0.09M | 0.17M | 1.43M | 3.45M | 3.40M | 3.65M | 3.01M | 6.93M | 9.66M | 8.32M | 7.45M | 6.14M | 5.23M | 4.38M | 3.23M | 1.88M | ||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -1.85M | 0.95M | -0.09M | 0.86M | -1.33M | -3.74M | 6.25M | 0.78M | 0.48M | -1.73M | 3.08M | -1.30M | 1.20M | -11.90M | 11.40M | 1.20M | 1.50M | -0.91M | 0.40M | 0.50M | ||||||||||||||
| Non Operating IncomeNon Op. Inc. | -1.81M | 0.98M | -1.04M | -0.90M | -3.05M | -5.42M | 4.22M | -0.68M | -1.14M | -2.96M | -23.92M | -13.94M | 0.71M | -14.20M | 49.72M | -2.70M | 13.70M | -6.96M | -19.05M | 5.19M | ||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||
| EBT | -39.53M | -39.38M | -24.14M | -37.09M | -42.12M | -42.77M | -7.43M | -39.83M | -45.51M | -45.87M | -77.19M | -52.70M | -58.22M | -82.07M | -26.14M | -67.94M | -47.52M | -78.59M | -91.52M | -38.65M | ||||||||||||||
| Tax ProvisionsTaxes | -6.36M | -5.38M | 17.57M | -0.03M | -0.06M | -0.01M | 19.55M | -0.01M | 0.04M | -0.02M | -0.02M | -0.01M | 0.05M | 0.02M | 1.46M | 2.23M | 0.40M | 0.53M | -1.16M | 0.47M | ||||||||||||||
| Profit After TaxPAT | -33.20M | -40.45M | -40.73M | -44.52M | -59.54M | -56.82M | -18.29M | -39.81M | -45.60M | -51.69M | -77.19M | -52.69M | -58.30M | -82.10M | -27.74M | -70.16M | -47.92M | -84.90M | -90.33M | -39.11M | ||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -33.17M | -33.99M | -41.71M | -37.06M | -42.06M | -42.77M | -26.98M | -39.81M | -45.55M | -45.85M | -77.17M | -52.69M | -58.27M | -82.09M | -27.61M | -70.16M | -47.92M | -79.12M | -90.36M | -39.11M | ||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -33.17M | -33.99M | -41.71M | -37.06M | -42.06M | -42.77M | -26.98M | -39.81M | -45.55M | -45.85M | -77.17M | -52.69M | -58.27M | -82.09M | -27.61M | -70.16M | -47.92M | -79.12M | -90.36M | -39.11M | ||||||||||||||
| Income towards Parent CompanyParent Net Inc | -33.17M | -33.99M | -41.71M | -37.06M | -42.06M | -42.77M | -26.98M | -39.81M | -45.55M | -45.85M | -77.17M | -52.69M | -58.27M | -82.09M | -27.61M | -70.16M | -47.92M | -79.12M | -90.36M | -39.11M | ||||||||||||||
| Net Income towards Common StockholdersNet Income | -33.17M | -33.99M | -41.71M | -37.06M | -42.06M | -42.77M | -26.98M | -39.81M | -45.55M | -45.85M | -77.17M | -52.69M | -58.27M | -82.09M | -27.61M | -70.16M | -47.92M | -79.12M | -90.36M | -39.11M | ||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||
| EPS (Basic) | -0.64 | -0.66 | -0.58 | -0.41 | -0.46 | -0.47 | -0.28 | -0.23 | -0.26 | -0.26 | -0.44 | -0.24 | -0.22 | -0.31 | -0.11 | -0.26 | -0.18 | -0.30 | -0.34 | -0.15 | ||||||||||||||
| EPS (Diluted) | -0.64 | -0.66 | -0.58 | -0.41 | -0.46 | -0.47 | -0.28 | -0.23 | -0.26 | -0.26 | -0.44 | -0.24 | -0.22 | -0.31 | -0.11 | -0.26 | -0.18 | -0.30 | -0.34 | -0.15 | ||||||||||||||
| Shares Outstanding | 51.56M | 51.56M | 72.08M | 90.91M | 90.93M | 91.24M | 94.99M | 173.83M | 173.86M | 173.98M | 173.94M | 222.17M | 266.03M | 266.08M | 255.16M | 266.13M | 266.14M | 266.14M | 266.14M | 266.16M | ||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 51.56M | 51.56M | 72.08M | 90.91M | 90.93M | 91.24M | 94.99M | 173.83M | 173.86M | 173.98M | 173.94M | 222.17M | 266.03M | 266.08M | 255.16M | 266.13M | 266.14M | 266.14M | 266.14M | 266.16M | ||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 179.84M | 179.84M | 179.84M | 180.06M | 262.00M | 262.00M | 262.61M | 262.86M | 263.03M | 354.86M | 354.97M | 355.05M | 355.05M | 355.07M | 355.03M | 355.03M | 355.04M | 355.04M | ||||||||||||||||
| EBITDA | -37.72M | -40.35M | -23.10M | -36.19M | -39.06M | -37.35M | -11.65M | -39.15M | -44.38M | -42.91M | -53.27M | -38.76M | -58.93M | -67.88M | -75.86M | -65.24M | -61.22M | -71.62M | -72.47M | -43.84M | ||||||||||||||
| Interest ExpensesInt Expense | 1.10M | 1.79M | 1.81M | 1.85M | 3.46M | 4.91M | 5.02M | 5.01M | 30.13M | 19.27M | 10.17M | 10.69M | -30.84M | 10.14M | -6.83M | 10.52M | 22.84M | -2.67M | ||||||||||||||||
| Tax Rate | 16.08% | 13.68% | -72.76% | 0.07% | 0.13% | 0.01% | -263.16% | 0.04% | -0.09% | 0.05% | 0.03% | 0.02% | -0.09% | -0.03% | -5.59% | -3.28% | -0.84% | -0.68% | 1.26% | -1.20% |